Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rolofylline in heart failure and renal impairment
NCT00729222Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Nov 2008
- Primary completion
- Mar 2009
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of rolofylline in heart failure (HF), sponsored by Merck & Co.. Started Nov 2008; status: completed.
02
Drugs
rolofylline
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00729222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00729222.